Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Non-alcoholic Fatty Liver Disease | 4 | 2021 | 393 | 1.300 |
Why?
|
| Liver Cirrhosis | 6 | 2024 | 875 | 0.880 |
Why?
|
| Apolipoproteins B | 5 | 2010 | 139 | 0.860 |
Why?
|
| Lipoproteins, VLDL | 5 | 2018 | 53 | 0.780 |
Why?
|
| Fatty Liver | 3 | 2024 | 204 | 0.700 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2021 | 144 | 0.600 |
Why?
|
| Lipase | 1 | 2018 | 87 | 0.550 |
Why?
|
| Lipoproteins | 1 | 2019 | 183 | 0.540 |
Why?
|
| Models, Molecular | 5 | 2010 | 1057 | 0.460 |
Why?
|
| Colectomy | 1 | 2015 | 86 | 0.450 |
Why?
|
| Liver Diseases | 1 | 2019 | 381 | 0.440 |
Why?
|
| Aspartate Aminotransferases | 1 | 2014 | 80 | 0.420 |
Why?
|
| Alanine Transaminase | 1 | 2014 | 154 | 0.400 |
Why?
|
| Colitis, Ulcerative | 1 | 2015 | 215 | 0.390 |
Why?
|
| Nutrition Surveys | 3 | 2024 | 293 | 0.380 |
Why?
|
| Cholesterol, HDL | 1 | 2014 | 379 | 0.370 |
Why?
|
| Patient Readmission | 1 | 2015 | 413 | 0.360 |
Why?
|
| Membrane Proteins | 1 | 2018 | 1569 | 0.330 |
Why?
|
| Cholesterol, LDL | 1 | 2014 | 604 | 0.320 |
Why?
|
| Antigens, CD | 4 | 2024 | 415 | 0.310 |
Why?
|
| Apyrase | 3 | 2019 | 20 | 0.310 |
Why?
|
| Blood Proteins | 2 | 2009 | 130 | 0.300 |
Why?
|
| Egg Proteins, Dietary | 2 | 2006 | 2 | 0.290 |
Why?
|
| Microfilament Proteins | 3 | 2009 | 269 | 0.290 |
Why?
|
| Protein Structure, Tertiary | 8 | 2010 | 718 | 0.280 |
Why?
|
| Phosphoproteins | 2 | 2009 | 420 | 0.270 |
Why?
|
| Cholangitis, Sclerosing | 2 | 2019 | 74 | 0.260 |
Why?
|
| Keratin-18 | 2 | 2016 | 9 | 0.240 |
Why?
|
| Lipoproteins, LDL | 3 | 2018 | 119 | 0.240 |
Why?
|
| Trypsin | 1 | 2005 | 81 | 0.230 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 1374 | 0.210 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2005 | 622 | 0.210 |
Why?
|
| Portal Vein | 1 | 2024 | 88 | 0.210 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2024 | 59 | 0.210 |
Why?
|
| Egg Proteins | 3 | 2010 | 29 | 0.200 |
Why?
|
| Venous Thrombosis | 1 | 2024 | 168 | 0.190 |
Why?
|
| Pancreatitis | 1 | 2023 | 137 | 0.190 |
Why?
|
| Neutrophils | 1 | 2024 | 349 | 0.190 |
Why?
|
| Middle Aged | 10 | 2024 | 27697 | 0.180 |
Why?
|
| Mutation, Missense | 3 | 2011 | 891 | 0.170 |
Why?
|
| United States | 5 | 2024 | 11310 | 0.170 |
Why?
|
| Humans | 24 | 2024 | 126753 | 0.160 |
Why?
|
| Adult | 8 | 2024 | 30410 | 0.160 |
Why?
|
| Protein Structure, Secondary | 4 | 2010 | 237 | 0.150 |
Why?
|
| Triglycerides | 3 | 2011 | 596 | 0.150 |
Why?
|
| Alcohol Drinking | 1 | 2021 | 338 | 0.150 |
Why?
|
| Phospholipases A2, Calcium-Independent | 1 | 2018 | 20 | 0.140 |
Why?
|
| Acyltransferases | 1 | 2018 | 62 | 0.140 |
Why?
|
| Protein Folding | 3 | 2009 | 214 | 0.140 |
Why?
|
| Adenoma | 1 | 2019 | 143 | 0.140 |
Why?
|
| Lipoproteins, HDL | 1 | 2018 | 96 | 0.140 |
Why?
|
| Defecation | 1 | 2017 | 34 | 0.130 |
Why?
|
| Male | 12 | 2024 | 62543 | 0.130 |
Why?
|
| ROC Curve | 2 | 2016 | 587 | 0.130 |
Why?
|
| Colonoscopy | 1 | 2019 | 244 | 0.130 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2018 | 276 | 0.130 |
Why?
|
| Purines | 1 | 2017 | 111 | 0.130 |
Why?
|
| Prospective Studies | 2 | 2018 | 6214 | 0.120 |
Why?
|
| Circular Dichroism | 2 | 2007 | 75 | 0.120 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2016 | 15 | 0.120 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2016 | 50 | 0.120 |
Why?
|
| Female | 11 | 2024 | 68330 | 0.120 |
Why?
|
| Th17 Cells | 1 | 2016 | 93 | 0.120 |
Why?
|
| Ileostomy | 1 | 2015 | 31 | 0.120 |
Why?
|
| Ascites | 1 | 2016 | 98 | 0.120 |
Why?
|
| Anastomosis, Surgical | 1 | 2015 | 165 | 0.110 |
Why?
|
| Steroids | 1 | 2015 | 157 | 0.110 |
Why?
|
| Treatment Failure | 1 | 2015 | 334 | 0.110 |
Why?
|
| Cardiovascular Diseases | 2 | 2024 | 2036 | 0.110 |
Why?
|
| Linear Models | 1 | 2016 | 681 | 0.110 |
Why?
|
| Feces | 1 | 2017 | 702 | 0.100 |
Why?
|
| Liver | 2 | 2024 | 1765 | 0.100 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 402 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 622 | 0.100 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2017 | 320 | 0.100 |
Why?
|
| Length of Stay | 2 | 2016 | 1377 | 0.100 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 3 | 2009 | 42 | 0.100 |
Why?
|
| Odds Ratio | 1 | 2015 | 1207 | 0.090 |
Why?
|
| Aged | 5 | 2024 | 20344 | 0.090 |
Why?
|
| Genotype | 1 | 2018 | 2595 | 0.090 |
Why?
|
| Phosphorylation | 2 | 2024 | 1536 | 0.090 |
Why?
|
| Apolipoprotein C-III | 1 | 2011 | 45 | 0.090 |
Why?
|
| Animals | 6 | 2024 | 33051 | 0.080 |
Why?
|
| Models, Chemical | 2 | 2007 | 81 | 0.080 |
Why?
|
| Heart Failure | 1 | 2023 | 2289 | 0.080 |
Why?
|
| Apolipoproteins C | 1 | 2010 | 11 | 0.080 |
Why?
|
| Lipid Metabolism Disorders | 1 | 2010 | 4 | 0.080 |
Why?
|
| Obesity | 1 | 2021 | 2332 | 0.080 |
Why?
|
| Disease Progression | 1 | 2016 | 2109 | 0.080 |
Why?
|
| Protein Binding | 3 | 2010 | 1661 | 0.080 |
Why?
|
| Time Factors | 2 | 2019 | 6134 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 2746 | 0.080 |
Why?
|
| Registries | 1 | 2016 | 1536 | 0.070 |
Why?
|
| Actins | 2 | 2009 | 311 | 0.070 |
Why?
|
| Kinetics | 2 | 2010 | 1090 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 2975 | 0.070 |
Why?
|
| Hypobetalipoproteinemias | 1 | 2007 | 3 | 0.070 |
Why?
|
| Retrospective Studies | 4 | 2024 | 17005 | 0.070 |
Why?
|
| Apolipoprotein B-100 | 1 | 2007 | 36 | 0.070 |
Why?
|
| Gelsolin | 1 | 2007 | 13 | 0.070 |
Why?
|
| Dimyristoylphosphatidylcholine | 1 | 2007 | 5 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 3262 | 0.070 |
Why?
|
| Chylomicrons | 1 | 2006 | 10 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2024 | 5114 | 0.060 |
Why?
|
| Proportional Hazards Models | 2 | 2024 | 1364 | 0.060 |
Why?
|
| Phosphatidylcholines | 1 | 2006 | 35 | 0.060 |
Why?
|
| Escherichia coli | 3 | 2009 | 962 | 0.060 |
Why?
|
| Incidence | 2 | 2024 | 3251 | 0.060 |
Why?
|
| Motion | 1 | 2006 | 39 | 0.060 |
Why?
|
| Biomarkers | 3 | 2023 | 3222 | 0.060 |
Why?
|
| Endoplasmic Reticulum | 1 | 2006 | 202 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2006 | 298 | 0.060 |
Why?
|
| Carrier Proteins | 2 | 2010 | 1011 | 0.060 |
Why?
|
| Spodoptera | 1 | 2005 | 28 | 0.060 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 3662 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2017 | 4472 | 0.060 |
Why?
|
| Fimbriae, Bacterial | 1 | 2004 | 40 | 0.060 |
Why?
|
| Biophysics | 1 | 2005 | 47 | 0.060 |
Why?
|
| Cross-Linking Reagents | 1 | 2005 | 50 | 0.060 |
Why?
|
| Hydrolysis | 1 | 2005 | 140 | 0.060 |
Why?
|
| Granulocytes | 1 | 2024 | 68 | 0.050 |
Why?
|
| Bacterial Adhesion | 1 | 2004 | 101 | 0.050 |
Why?
|
| Risk Factors | 3 | 2024 | 10555 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2024 | 3709 | 0.050 |
Why?
|
| Macrophages | 2 | 2019 | 640 | 0.050 |
Why?
|
| Ketone Bodies | 1 | 2023 | 38 | 0.050 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2024 | 137 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2015 | 3066 | 0.050 |
Why?
|
| Acetylation | 1 | 2023 | 181 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 4504 | 0.050 |
Why?
|
| Calcium | 1 | 2007 | 1031 | 0.050 |
Why?
|
| Cause of Death | 1 | 2024 | 484 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2023 | 348 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2023 | 333 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 1222 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2024 | 4954 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2005 | 756 | 0.040 |
Why?
|
| Acute Disease | 1 | 2023 | 1135 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2024 | 576 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2023 | 1398 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2006 | 929 | 0.040 |
Why?
|
| Pyridines | 1 | 2019 | 251 | 0.030 |
Why?
|
| Dietary Fiber | 1 | 2017 | 78 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 89 | 0.030 |
Why?
|
| Income | 1 | 2017 | 130 | 0.030 |
Why?
|
| Exosomes | 1 | 2017 | 58 | 0.030 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2016 | 6 | 0.030 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2017 | 104 | 0.030 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2017 | 70 | 0.030 |
Why?
|
| Adenosine | 1 | 2017 | 126 | 0.030 |
Why?
|
| Aging | 1 | 2023 | 1193 | 0.030 |
Why?
|
| Inflammation | 1 | 2023 | 1420 | 0.030 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2016 | 67 | 0.030 |
Why?
|
| Educational Status | 1 | 2017 | 274 | 0.030 |
Why?
|
| Adenosine Deaminase | 1 | 2016 | 90 | 0.030 |
Why?
|
| Dysbiosis | 1 | 2017 | 138 | 0.030 |
Why?
|
| Reference Values | 1 | 2017 | 683 | 0.030 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2015 | 52 | 0.030 |
Why?
|
| Image-Guided Biopsy | 1 | 2015 | 40 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2016 | 124 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2017 | 354 | 0.030 |
Why?
|
| Mice | 2 | 2024 | 17596 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2015 | 301 | 0.030 |
Why?
|
| Binding Sites | 2 | 2010 | 1185 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2016 | 189 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2016 | 759 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2016 | 1014 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 2541 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2016 | 754 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 783 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 1309 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2009 | 3584 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1259 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1597 | 0.020 |
Why?
|
| Young Adult | 2 | 2017 | 9665 | 0.020 |
Why?
|
| Gene Expression | 1 | 2016 | 1482 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 2011 | 79 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2011 | 87 | 0.020 |
Why?
|
| Microsomes, Liver | 1 | 2011 | 96 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2015 | 933 | 0.020 |
Why?
|
| Lipoproteins, IDL | 1 | 2010 | 6 | 0.020 |
Why?
|
| Brefeldin A | 1 | 2010 | 11 | 0.020 |
Why?
|
| Microsomes | 1 | 2010 | 37 | 0.020 |
Why?
|
| Threonine | 1 | 2010 | 60 | 0.020 |
Why?
|
| Chickens | 1 | 2010 | 284 | 0.020 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2017 | 796 | 0.020 |
Why?
|
| Alanine | 1 | 2010 | 162 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2009 | 52 | 0.020 |
Why?
|
| Actin Cytoskeleton | 1 | 2009 | 48 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 2397 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2011 | 276 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 4429 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 2883 | 0.020 |
Why?
|
| Hospitalization | 1 | 2016 | 1874 | 0.020 |
Why?
|
| Family Health | 1 | 2007 | 248 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 1293 | 0.010 |
Why?
|
| Fimbriae Proteins | 1 | 2004 | 20 | 0.010 |
Why?
|
| Cell Line | 1 | 2010 | 2560 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2004 | 307 | 0.010 |
Why?
|
| Escherichia coli Proteins | 1 | 2004 | 297 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 2304 | 0.010 |
Why?
|
| Infant | 1 | 2016 | 12771 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2016 | 14347 | 0.010 |
Why?
|
| Adolescent | 1 | 2016 | 20002 | 0.010 |
Why?
|
| Child | 1 | 2016 | 25101 | 0.010 |
Why?
|
| Mutation | 1 | 2004 | 5941 | 0.010 |
Why?
|